Genetic Fate Mapping Using Site-Specific Recombinases

    January 2010 in “ Methods in Enzymology
    Emilie Legué, Alexandra L. Joyner
    Image of study
    TLDR The document concludes that careful design of genetic fate mapping experiments is crucial for accurate cell lineage tracing in mice.
    The document from 2010 details the use of genetic fate mapping with site-specific recombinases (SSRs) to trace cell lineages in mice, focusing on the methodology and considerations for successful experiments. It explains the use of SSRs like Cre and Flp recombinases, which are activated by ligands such as tamoxifen, to induce recombination at specific DNA sequences in reporter alleles, allowing for temporal control over cell marking. The document discusses various fate mapping techniques, including cumulative, inducible, clonal, and intersectional methods, and the importance of selecting appropriate promoters and reporter alleles for specific cell populations. It also addresses the potential toxicity of SSRs and ligands, the variability in recombination efficiency, and the need to test for noninduced labeling. Techniques like the Brainbow system and Mosaic Analysis with Double Markers (MADM) are mentioned for their ability to distinguish multiple recombination events and to study mutant cell fates within a wild-type environment. The document emphasizes the need for careful experimental design, including the choice of SSR and reporter allele, the genetic background of the mice, and the administration of ligands, to ensure accurate and robust cell lineage tracing.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community 2 months | 30M | Topical finasteride/minoxidil

      in Progress Pictures  83 upvotes 2 weeks ago
      A 30-year-old man shares his positive experience with a topical solution containing 0.1% finasteride, 7.5% minoxidil, tretinoin, caffeine, and fluocinolone acetonide after experiencing side effects from oral finasteride and no results from 5% minoxidil. He reports noticeable hair growth in two months with minimal side effects, attributing success to the new topical combination.

      community Need supplemental products in addition to oral minoxidil and oral dutasteride

      in Product  1 upvotes 4 months ago
      The user has been using oral minoxidil and dutasteride for hair loss without success and is considering adding topical 17α-estradiol, Pyrilutamide, Clascoterone, or cetirizine. They have confirmed low serum DHT levels and are exploring additional treatments due to genetic sensitivity to DHT and prostaglandin D2.

      community Does dutasteride stop hair loss forever?

      in Finasteride/Dutasteride  38 upvotes 1 year ago
      Dutasteride and finasteride can significantly slow or halt hair loss, with some users experiencing regrowth, but results vary. Lifestyle factors and individual genetic predispositions also play a role in hair loss outcomes.

      community 6 month update of 1 mg fin only

      in Progress Pictures  30 upvotes 2 years ago
      A user shared a 6-month hair loss progress update using 1 mg finasteride, plans to start minoxidil and RU58841 due to severe shedding, and seeks advice. Others suggest maintaining treatment, switching to different medications, and considering more aggressive treatments due to strong genetic predisposition to baldness.

      community 100 Day Progress & Managing Realistic Expectations (FTM 24)

      in Progress Pictures  96 upvotes 1 month ago
      A trans man experiencing hair loss after starting testosterone treatment has seen positive results using topical minoxidil and finasteride, though his hair remains thin. He is considering continuing his current treatment and exploring additional options like microneedling and Breezula, while acknowledging the impact of testosterone on hair loss.

    Related Research

    1 / 1 results